Cann Global Limited (CGB:ASX)


right-arrow Created with Sketch. 0.001 (25%)
MCAP $28.62M
Last trade 16.10pm 22/10/2021 20mins delayed

Latest Announcements

30/09/2021CGBCann Global Limited
30/09/2021CGBCann Global Limited
31/08/2021 Price SensitivePSCGBCann Global Limited
30/08/2021CGBCann Global Limited
30/08/2021CGBCann Global Limited
19/08/2021CGBCann Global Limited
16/08/2021CGBCann Global Limited
13/08/2021CGBCann Global Limited

Company Overview

Cann Global Limited is an Australia-based company engaged in medicinal cannabis and the natural food and beauty business. The Company’s divisions include Food, Hemp Cultivation, and Processing, Skincare, Medicine, and Mining division. The Food division is focused on the production and distribution of healthy and nutritious plant-based food products for discerning Australian and Asian consumers. Hemp Cultivation and Processing division includes hulling in Australia, and broad-acre industrial cannabidiol (CBD) hemp cultivation and processing in Asia where growing conditions are ideal. The Skincare division, which includes oil, serum, and a cream product all contain hemp seed oil as the primary active ingredient. The Medicine division is responsible for research into the medicinal uses of cannabis, including research into the benefits for those with auto-immune diseases. The Mining division holds bauxite assets in the South Johnstone project, Queensland (EPM 18463).

CGB in the news

Cann Global (CGB) shares jump after its cannabis hard pills were received…
Cann Global (CGB) has entered a binding agreement with Western Sydney University’s…
Cann Global’s (CGB) joint venture (JV) partner has been handed a key…
Cann Global’s (CGB) joint venture partner, Canntab Therapeutics, has been granted an…

Search Previous Announcements